 Innoviva Inc NASDAQ: INVA has agreed to acquire Entasis Therapeutics Holdings Inc NASDAQ: ETTX at 2.20 per share in cash. Innoviva currently owns approximately 60 of the outstanding shares of Entasis common stock. 